Nu Skin Enterprises (NYSE:NUS - Get Free Report) issued its quarterly earnings data on Friday. The company reported $0.14 earnings per share for the quarter, missing the consensus estimate of $0.15 by ($0.01), FiscalAI reports. Nu Skin Enterprises had a return on equity of 8.14% and a net margin of 10.79%.The business had revenue of $320.61 million during the quarter, compared to analyst estimates of $329.70 million.
Nu Skin Enterprises Price Performance
Shares of Nu Skin Enterprises stock traded up $0.11 during midday trading on Friday, hitting $7.13. 784,355 shares of the company traded hands, compared to its average volume of 514,402. The stock has a market cap of $343.31 million, a price-to-earnings ratio of 2.23 and a beta of 1.03. The company has a debt-to-equity ratio of 0.25, a quick ratio of 1.40 and a current ratio of 2.08. The firm's fifty day moving average price is $7.48 and its 200-day moving average price is $9.21. Nu Skin Enterprises has a 12 month low of $6.34 and a 12 month high of $14.62.
Nu Skin Enterprises Announces Dividend
The business also recently declared a quarterly dividend, which will be paid on Wednesday, June 10th. Investors of record on Friday, May 29th will be issued a dividend of $0.06 per share. The ex-dividend date of this dividend is Friday, May 29th. This represents a $0.24 annualized dividend and a dividend yield of 3.4%. Nu Skin Enterprises's payout ratio is 7.50%.
Analyst Upgrades and Downgrades
NUS has been the subject of several analyst reports. Wall Street Zen cut shares of Nu Skin Enterprises from a "buy" rating to a "hold" rating in a research note on Saturday, February 14th. Weiss Ratings restated a "hold (c)" rating on shares of Nu Skin Enterprises in a research report on Thursday, January 22nd. Finally, Zacks Research upgraded shares of Nu Skin Enterprises from a "strong sell" rating to a "hold" rating in a research report on Monday, April 13th. Two research analysts have rated the stock with a Hold rating, Based on data from MarketBeat, Nu Skin Enterprises presently has a consensus rating of "Hold".
View Our Latest Research Report on NUS
Institutional Investors Weigh In On Nu Skin Enterprises
Several hedge funds and other institutional investors have recently made changes to their positions in NUS. Charles Schwab Investment Management Inc. grew its holdings in shares of Nu Skin Enterprises by 22.5% during the 4th quarter. Charles Schwab Investment Management Inc. now owns 2,621,785 shares of the company's stock valued at $25,222,000 after purchasing an additional 481,231 shares during the last quarter. AQR Capital Management LLC grew its holdings in shares of Nu Skin Enterprises by 59.2% during the 4th quarter. AQR Capital Management LLC now owns 799,120 shares of the company's stock valued at $7,688,000 after purchasing an additional 297,071 shares during the last quarter. Millennium Management LLC grew its holdings in shares of Nu Skin Enterprises by 1,167.2% during the 4th quarter. Millennium Management LLC now owns 275,100 shares of the company's stock valued at $2,646,000 after purchasing an additional 253,390 shares during the last quarter. Dimensional Fund Advisors LP grew its holdings in shares of Nu Skin Enterprises by 16.4% during the 4th quarter. Dimensional Fund Advisors LP now owns 1,373,372 shares of the company's stock valued at $13,212,000 after purchasing an additional 193,987 shares during the last quarter. Finally, Bridgeway Capital Management LLC grew its holdings in shares of Nu Skin Enterprises by 84.4% during the 3rd quarter. Bridgeway Capital Management LLC now owns 396,725 shares of the company's stock valued at $4,836,000 after purchasing an additional 181,601 shares during the last quarter. 82.84% of the stock is owned by institutional investors.
Key Headlines Impacting Nu Skin Enterprises
Here are the key news stories impacting Nu Skin Enterprises this week:
- Positive Sentiment: Board declared a quarterly cash dividend of $0.06/share (annualized yield ~3.6%), payable June 10 to holders of record May 29 — supports income seekers and signals capital return priority. Dividend Announcement
- Neutral Sentiment: Company said Q1 revenue of $320.6M was within its guidance range, and provided slide deck/press materials for the quarter — useful for digging into channel and regional detail. Q1 Press Materials
- Neutral Sentiment: Stonegate Capital Partners updated coverage and reiterated results context (reported adj. NI and adj. EPS figures) — shows analyst attention but no headline rating/action in the release. Stonegate Coverage Update
- Neutral Sentiment: Full Q1 earnings call transcript is available for investors who want management commentary on trends (customer counts, FX, product mix). Useful for assessing whether weakness is cyclical or structural. Earnings Call Transcript
- Negative Sentiment: Q1 EPS of $0.14 missed the consensus $0.15 and declined from $0.23 a year ago; revenue of $320.6M missed consensus ~$329.7M — a modest earnings and top‑line shortfall that pressured sentiment. Earnings Miss
- Negative Sentiment: Management issued cautious guidance: Q2 EPS $0.150–0.250 (consensus ~0.230) and FY26 EPS $0.700–1.100 (consensus ~1.00); revenue ranges are around or slightly below consensus. The guidance midpoint is generally conservative, which likely drove the stock decline. Q1 Results & Guidance
About Nu Skin Enterprises
(
Get Free Report)
Nu Skin Enterprises, Inc is a Utah-based direct selling company that develops and distributes personal care products and dietary supplements. Operating through a network marketing model, Nu Skin offers a portfolio of wellness, anti-aging skin care, hair care and nutritional products designed to support healthy living and appearance. The company leverages independent distributors to market its offerings directly to consumers across multiple channels, including online platforms and localized events.
Founded in 1984 by Blake M.
Further Reading

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Nu Skin Enterprises, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Nu Skin Enterprises wasn't on the list.
While Nu Skin Enterprises currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Thinking about investing in Meta, Roblox, or Unity? Click the link to learn what streetwise investors need to know about the metaverse and public markets before making an investment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.